EIM
NVIV

Emerson Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Emerson Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$518K Hold
4
– – 0.1% 89
2015
Q4 		$534K Buy
4
+2
+100% +$297K 0.1% 88
2015
Q3 		$396K Sell
2
-1
-33% -$234K 0.08% 101
2015
Q2 		$790K Buy
+3
New +$793K 0.15% 83

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

Emerson Investment Management's NVIV Position: Q1 2016 in Review

Emerson Investment Management held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q1 2016 at 4 shares worth $518K. The position accounts for 0.1% of the portfolio, ranked #89.

Emerson Investment Management first reported a position in NVIV in Q2 2015 and has held it in 4 quarters since. The position peaked at $790K in Q2 2015. 46 funds tracked by Wall St. Rank hold NVIV as of Q1 2016.

  • Emerson Investment Management held 4 shares of InVivo Therapeutics Holdings Corp worth $518K as of Q1 2016.
  • Emerson Investment Management left its InVivo Therapeutics Holdings Corp share count unchanged in Q1 2016.
  • InVivo Therapeutics Holdings Corp made up 0.1% of Emerson Investment Management's portfolio in Q1 2016, its #89 holding.
  • Emerson Investment Management first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and has held it in 4 quarters since.
  • Emerson Investment Management's InVivo Therapeutics Holdings Corp position peaked at $790K in Q2 2015.
  • 46 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.